ADVANTAGE MULTI 18 SOLUTION Kanada - inglise - Health Canada

advantage multi 18 solution

elanco canada limited - imidacloprid; moxidectin - solution - 80mg; 8mg - imidacloprid 80mg; moxidectin 8mg - cats

ADVANTAGE MULTI 55 SOLUTION Kanada - inglise - Health Canada

advantage multi 55 solution

elanco canada limited - imidacloprid; moxidectin - solution - 250mg; 62.5mg - imidacloprid 250mg; moxidectin 62.5mg - dogs

ADVANTAGE MULTI 20 SOLUTION Kanada - inglise - Health Canada

advantage multi 20 solution

elanco canada limited - imidacloprid; moxidectin - solution - 100mg; 25mg - imidacloprid 100mg; moxidectin 25mg - dogs

ADVANTAGE MULTI 10 SOLUTION Kanada - inglise - Health Canada

advantage multi 10 solution

elanco canada limited - imidacloprid; moxidectin - solution - 40mg; 10mg - imidacloprid 40mg; moxidectin 10mg - dogs

ADVANTAGE MULTI 100 SOLUTION Kanada - inglise - Health Canada

advantage multi 100 solution

elanco canada limited - imidacloprid; moxidectin - solution - 400mg; 100mg - imidacloprid 400mg; moxidectin 100mg - dogs

ADVANTAGE DRONTAL FOR MEDIUM DOGS ALLWORMER TABLET Austraalia - inglise - APVMA (Australian Pesticides and Veterinary Medicines Authority)

advantage drontal for medium dogs allwormer tablet

vetoquinol australia pty ltd - pyrantel as pyrantel embonate; praziquantel; febantel - oral tablet - pyrantel as pyrantel embonate anthelmintic active 49.8 mg; praziquantel anthelmintic active 50.0 mg; febantel carbamate active 250.0 mg - parasiticides

ADVANTAGE DRONTAL FOR CATS ALLWORMER TABLET Austraalia - inglise - APVMA (Australian Pesticides and Veterinary Medicines Authority)

advantage drontal for cats allwormer tablet

vetoquinol australia pty ltd - pyrantel as pyrantel embonate; praziquantel - oral tablet - pyrantel as pyrantel embonate anthelmintic active 80.0 mg; praziquantel anthelmintic active 20.0 mg - parasiticides

Advantage I-125 Brachytherapy Sources in a Capped Vial - Radionuclide source, therapeutic, brachytherapy, manual, permanent impl Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

advantage i-125 brachytherapy sources in a capped vial - radionuclide source, therapeutic, brachytherapy, manual, permanent impl

alphaxrt pty ltd - 38303 - radionuclide source, therapeutic, brachytherapy, manual, permanent implant - the seeds are placed in the tumor and the tumor then is exposed to gamma radiation from the seeds. this gamma radiation destroys the tumor cells by damaging the cell nucleus and other cell proteins and contents, preventing the cells from reproduction. the damaged cells cannot survive with the modified chromosomes and damaged proteins. the main intended use is the treatment of prostate cancer tumors. the i-125 advantage brachytherapy seeds are indicated for the treatment of selected localized tumours. the main intended use is the treatment of prostate cancer tumours.

Terumo Radifocus Glidewire Advantage Guidewire Singapur - inglise - HSA (Health Sciences Authority)

terumo radifocus glidewire advantage guidewire

terumo asia holdings pte ltd - cardiovascular - the glidewire advantage is designed to direct a catheter to the desired anatomical location during diagnostic or interventional procedures, except for central circulatory system.

ADVANTAGE KILTIX COLLAR FOR DOGS TICKS Austraalia - inglise - APVMA (Australian Pesticides and Veterinary Medicines Authority)

advantage kiltix collar for dogs ticks

elanco australasia pty ltd - propoxur; flumethrin - collar, medalion - propoxur carbamate-methylcarbamate active 100.0 g/kg; flumethrin pyrethroid active 22.5 g/kg - parasiticides